Dissecting the non-canonical functions of telomerase

Cytogenetic and Genome Research

Volumn 122, Issue 3-4, 2009, Pages 273-280

  Parkinson, E K ^a   Fitchett, C ^a   Cereser, B ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GROWTH FACTOR; MYC PROTEIN; PROTEIN P19; PROTEIN P53; RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RIBONUCLIEC ACID COMPONENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; CARCINOGENESIS; CATALYSIS; CELL ACTIVATION; CELL AGING; CELL CYCLE; CELL IMMORTALIZATION; CELL PROTECTION; CELL SURVIVAL; DNA DAMAGE; DNA TEMPLATE; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDERMIS CELL; GENE EXPRESSION; GENE FUSION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HAIR FOLLICLE; HUMAN; KERATINOCYTE; MAMMARY GLAND; NEOPLASM; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; STEM CELL; TELOMERE; TUMOR CELL;

APOPTOSIS; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, P53; GENES, RAS; HAIR; HAIR FOLLICLE; HUMANS; MUTATION; NEOPLASMS; NEURONS; STEM CELLS; TELOMERASE;

EID: 59649125563     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167813     Document Type: Review

References (75)

1. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, et al: Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121:1046-1053 (2008).
2. Argyris TS: Epidermal growth following a single application of 12-O-tetradecanoyl-phorbol-13-acetate in mice. Am J Pathol 98:639-648 (1980).
3. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, et al: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99:8191-8196 (2002).
4. Bednarek A, Budunova I, Slaga TJ, Aldaz CM: Increased telomerase activity in mouse skin premalignant progression. Cancer Res 55:4566-4569 (1995).
5. Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ: Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 8:1127-1133 (1993).
6. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, et al: Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94:14559-14563 (1997).
7. Broccoli D, Godley LA, Donehower LA, Varmus HE, de Lange T: Telomerase activation in mouse mammary tumors: Lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 16:3765-3772 (1996).
8. Brown K, Strathdee D, Bryson S, Lambie W, Balmain A: The malignant capacity of skin tumors induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr Biol 8:516-524 (1998).
9. Buday L, Downward J: Epidermal growth factor regulates p21 ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611-620 (1993).
10. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R, Balmain A: Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene 6:2363-2369 (1991).
11. Cao Y, Li H, Deb S, Liu JP: TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21:3130-3138 (2002).
12. Cao Y, Bryan TM, Reddel RR: Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 99:1092-1099 (2008).
13. Cayuela ML, Flores JM, Blasco MA: The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep 6:268-274 (2005).
14. Cerezo A, Stark HJ, Moshir S, Boukamp P: Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 121:110-119 (2003).
15. Chadeneau C, Siegel P, Harley CB, Muller WJ, Bacchetti S: Telomerase activity in normal and malignant murine tissues. Oncogene 11:893-898 (1995).
16. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, et al: TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 4:e10 (2008).
17. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, et al: Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA 95:14723-14728 (1998).
18. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, et al: TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542 (1996).
19. Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, et al: Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function. Cell Death Differ 12:1429-1438 (2005).
20. Effros RB: Telomerase induction in T cells: a cure for aging and disease? Exp Gerontol 42:416-420 (2007).
21. Flores I, Cayuela ML, Blasco MA: Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309:1253-1256 (2005).
22. Folini M, Brambilla C, Villa R, Gandellini P, Vignati S, et al: Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer 41:624-634 (2005).
23. Fu W, Begley JG, Killen MW, Mattson MP: Antiapoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 274:7264-7271 (1999).
24. Fu W, Killen M, Culmsee C, Dhar S, Pandita TK, Mattson MP: The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J Mol Neurosci 14:3-15 (2000).
25. Gage FH: Mammalian neural stem cells. Science 287:1433-1438 (2000).
26. Geserick C, Tejera A, Gonzalez-Suarez E, Klatt P, Blasco MA: Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25:4310-4319 (2006).
27. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26:114-117 (2000).
28. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTert, in basal keratinocytes. EMBO J 20:2619-2630 (2001).
29. Greaves M: Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 12:127-128 (1996).
30. Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A: Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogene 6:1465-1470 (1991).
31. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA: Creation of human tumour cells with defined genetic elements. Nature 400:464-468 (1999).
32. Harley CB: Telomerase and cancer therapeutics. Nat Rev Cancer 8:167-179 (2008).
33. Holt SE, Wright WE, Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16:2932-2939 (1996).
34. Jagadeesh S, Banerjee PP: Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun 347:774-780 (2006).
35. Kang HJ, Choi YS, Hong SB, Kim KW, Woo RS, et al: Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J Neurosci 24:1280-1287 (2004).
36. Kedde M, le Sage C, Duursma A, Zlotorynski E, van Leeuwen B, et al: Telomerase-independent regulation of ATR by human telomerase RNA. J Biol Chem 281:40503-40514 (2006).
37. Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ: p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways. PLoS Biol 2:E242 (2004).
38. Kipling D, Cooke HJ: Hypervariable ultra-long telomeres in mice. Nature 347:400-402 (1990).
39. Klapper W, Shin T, Mattson MP: Differential regulation of telomerase activity and TERT expression during brain development in mice. J Neurosci Res 64:252-260 (2001).
40. Lee J, Sung YH, Cheong C, Choi YS, Jeon HK, et al: TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 27:3754-3760 (2008).
41. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, et al: Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 64:4833-4840 (2004).
42. Li S, Crothers J, Haqq CM, Blackburn EH: Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem 280:23709-23717 (2005).
43. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A: Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res 55:5168-5172 (1995).
44. Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, et al: Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: Activation of the epiregulin gene. Cancer Res 63:1743-1747 (2003).
45. Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, et al: Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 14:1955-1964 (1997).
46. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B: Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ 7:1291-1304 (1996).
47. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al: Telomerase maintains telomere structure in normal human cells. Cell 114:241-253 (2003).
48. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, et al: The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 102:8222-8227 (2005).
49. Mattson MP, Fu W, Zhang P: Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev 122:659-671 (2001).
50. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, et al: Specific deletion of focal adhesion kinase suppresses tumour formation and blocks malignant progression. Genes Dev 18:2998-3003 (2004).
51. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959 (1997).
52. Oh S, Song Y, Yim J, Kim TK: The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 274:37473-37478 (1999).
53. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN: Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 164:215-226 (2000).
54. Parkinson EK, Minty F: Anticancer therapy targeting telomeres and telomerase: current status. BioDrugs 21:375-385 (2007).
55. Quintanilla M, Brown K, Ramsden M, Balmain A: Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80 (1986).
56. Rahman R, Latonen L, Wiman KG: hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 24:1320-1327 (2005).
57. Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108:113-117 (1997).
58. Rubin Grandis J, Tweardy DJ, Melhem MF: Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res 4:13-20 (1998).
59. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al: Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712 (1999).
60. Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, et al: Alterations of the p53 tumour suppressor gene during mouse skin tumour progression. Cancer Res 51:6615-6621 (1991).
61. Santos JH, Meyer JN, Skorvaga M, Annab LA, Van Houten B: Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage. Aging Cell 3:399-411 (2004).
62. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, et al: Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-1052 (2005).
63. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ: Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1 , within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355-361 (1992).
64. Siegl-Cachedenier I, Flores I, Klatt P, Blasco MA: Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres. J Cell Biol 179:277-290 (2007).
65. Smith LL, Coller HA, Roberts JM: Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-479 (2003).
66. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013-1021 (1997).
67. Soder AI, Going JJ, Kaye SB, Keith WN: Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene 16:979-983 (1998).
68. Stampfer MR, Garbe J, Levine G, Lichtsteiner S, Vasserot AP, Yaswen P: Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4a(-) human mammary epithelial cells. Proc Natl Acad Sci USA 98:4498-4503 (2001).
69. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al: Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99:12606-12611 (2002).
70. Trapp S, Parcells MS, Kamil JP, Schumacher D, Tischer BK, et al: A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med 203:1307-1317 (2006).
71. Vassar R, Fuchs E: Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 5:714-727 (1991).
72. Wei G, Ku S, Ma GK, Saito S, Tang AA, et al: Hipk2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci USA 104:13040-13045 (2007).
73. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, et al: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17:498-502 (1997).
74. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, et al: Direct activation of TERT transcription by c-MYC. Nat Genet 21:220-224 (1999).
75. Zhu H, Fu W, Mattson MP: The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem 75:117-124 (2000).